Gilead Sciences Inc buy UBS Group AG
Start price
07.01.26
/
50%
€105.00
Target price
07.01.27
€123.92
Performance (%)
13.98%
Price
28.07.26
€118.04
Summary
This prediction is currently active. The prediction currently has a performance of 13.98%. Dividends of €1.64 are taken into consideration when calculating the performance. This prediction currently runs until 07.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Gilead Sciences Inc | 3.326% | 3.326% |
| iShares Core DAX® | 1.717% | 3.368% |
| iShares Nasdaq 100 | -4.565% | -4.238% |
| iShares Nikkei 225® | -7.120% | -11.869% |
| iShares S&P 500 | -0.894% | 1.687% |
Comments by UBS_Group_AG for this prediction
In the thread Gilead Sciences Inc diskutieren
Gilead Sciences (NASDAQ:GILD) had its "buy" rating reaffirmed by analysts at UBS Group AG. They now have a $145.00 price target on the stock, up previously from $112.00.
Ratings data for GILD provided by MarketBeat
Stopped prediction by UBS_Group_AG for Gilead Sciences Inc
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€115.48
26.01.26
26.01.26
€130.56
26.01.27
26.01.27
3.64%
28.07.26
28.07.26
